NEW YORK, Oct. 10 - GlaxoSmithKline and First Genetic Trust have entered into a broad SNP-related research collaboration to define why some individuals are susceptible to certain serious adverse events, the companies said on Wednesday.

GlaxoSmithKline will sponsor the study and conduct all analyses, while First Genetic Trust will provide its independent secure genetic banking services to store biological samples and medical data.

First Genetic Trust will also ensure that participating patients’ privacy is protected.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.